Jiang Zehui, Zhang Jun, Lu Yuanan
Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.
Department of Cardiovascular Medicine, The 908th Hospital of Chinese People's Liberation Army Joint Logistic Support Force, Nanchang 330006, China.
Int J Nephrol. 2020 May 18;2020:3490641. doi: 10.1155/2020/3490641. eCollection 2020.
To explore the protective effect and mechanism of rosuvastatin on acute renal injury induced by a nonionic hypotonic contrast medium in rats.
Forty-eight healthy adult SD rats were randomly divided into three groups: normal control group (NC); contrast medium control group (CM); and rosuvastatin intervention group (RI). The RI group was intragastrically administered with a 10 mg/kg of rosuvastatin 12 h prior to the contrast exposure. All rats in CM and RI groups were inoculated with 10 mL/kg of chemical (IV) while the same volume of saline for the NC group. At 24 h and 72 h posttreatments, pathomorphological changes of renal tubules were documented, respectively, and several biochemical indicators were tested to assess renal injury of experimental rats.
Compared with the CM group, rats in the RI group showed significantly reduced injury of kidneys and decreased levels of biochemical indicators such as blood Scr, blood Cys-C, urine NAG, urine 1-MG, and urine mALB. The serum Hs-CRP in the CM group increased significantly from 24 h to 72 h ( < 0.05), but this was not observed in the rats of the RI group. In addition, SOD activity in the RI group was significantly increased ( < 0.01) while SOD activity in renal tissue decreased significantly with time in the CM group ( < 0.05).
Short-term intervention with rosuvastatin can lead to reduced kidney damage associated with the contrast agent by reducing the levels of inflammatory factors and oxidative stress. Thus, rosuvastatin intervention has a protective effect on rats from contrast-induced nephropathy.
探讨瑞舒伐他汀对大鼠非离子低渗造影剂所致急性肾损伤的保护作用及机制。
将48只健康成年SD大鼠随机分为三组:正常对照组(NC);造影剂对照组(CM);瑞舒伐他汀干预组(RI)。RI组在造影剂暴露前12小时给予10mg/kg瑞舒伐他汀灌胃。CM组和RI组所有大鼠均注射10mL/kg化学造影剂(IV),而NC组注射相同体积的生理盐水。在处理后24小时和72小时,分别记录肾小管的病理形态学变化,并检测多项生化指标以评估实验大鼠的肾损伤。
与CM组相比,RI组大鼠的肾脏损伤明显减轻,血Scr、血Cys-C、尿NAG、尿1-MG和尿mALB等生化指标水平降低。CM组血清Hs-CRP从24小时到72小时显著升高(<0.05),但RI组大鼠未观察到这种情况。此外,RI组SOD活性显著升高(<0.01),而CM组肾组织中SOD活性随时间显著降低(<0.05)。
瑞舒伐他汀短期干预可通过降低炎症因子水平和氧化应激来减轻与造影剂相关的肾损伤。因此,瑞舒伐他汀干预对大鼠造影剂肾病具有保护作用。